Reference‐free thio‐succinimide isomerization characterization by electron‐activated dissociation
Rapid Communications in Mass Spectrometry · 2024
DOI: 10.1002/rcm.9910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2024. Verfasst von Junyan Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, California, USA. Hauptthemen laut MEDLINE: Sulfhydryl Compounds, Succinimides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.
Abstract (Originalsprache)
Rationale
Isomerism can be an important aspect in pharmaceutical drug development. Identification of isomers can provide insights into drug pharmacology and contribute to better design of drug molecules. The general approaches to differentiate isomers include Fourier‐transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR), and circular dichroism. Additionally, a commonly used method to differentiate isomers is liquid chromatography coupled with mass spectrometry (LC‐MS). Notably, LC‐MS is routinely applied to leucine and isoleucine differentiation to facilitate protein sequencing. This work focuses on isomer differentiation of widely employed thio‐succinimide structure bridging the antibody backbone and linker‐payload of antibody‐drug conjugates (ADCs). Thio‐succinimide hydrolysis stabilizes the payload‐protein structure while generating a pair of constitutional isomers: thio‐aspartyl and thio‐isoaspartyl.
Methods
This paper introduces a hybrid method using ligand binding assay (LBA) and liquid chromatography coupled with tandem MS (LC–MS/MS) to reveal isomerization details of thio‐succinimide hydrolysis over time in plasma samples incubated with ADC. Application of two orthogonal dissociation methods, collision‐induced dissociation (CID) and electron‐activated dissociation (EAD) revealed different MS/MS spectra for this pair of isomers. This observation enables a unique approach in distinguishing thio‐succinimide hydrolysis isomers.
Results
We observed signature [R 1 + Thio + 57 + H] + , [R 2 + Succ + H 2 O − 57 + H] + , and [R 2 + Succ + H 2 O − 44 + 2H] 2+ product ions (Succ = succinimide) that differentiated thio‐aspartyl and thio‐isoaspartyl isomers using EAD. A newly discovered [R 2 + ThioSucc + H 2 O − 44 + 2H] 2+ ion also served as additional evidence that further supported our findings.
Conclusions
This study is a first‐to‐date identification of thio‐succinimide hydrolysis isomers without using synthesized reference materials. This approach should be applicable to all thio‐succinimide‐linked molecules. Correct identification of thio‐succinimide hydrolysis isomers may eventually benefit the development of ADCs in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, California, USA.
ORCID-Profile: Anton I Rosenbaum
Förderung
- AstraZeneca
Zitieren
APA
Yang, J., Yuan, J., Huang, Y., & Rosenbaum, A. I. (2024). Reference‐free thio‐succinimide isomerization characterization by electron‐activated dissociation. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9910
Vancouver
Yang J, Yuan J, Huang Y, Rosenbaum AI. Reference‐free thio‐succinimide isomerization characterization by electron‐activated dissociation. Rapid Communications in Mass Spectrometry. 2024. doi:10.1002/rcm.9910
BibTeX
@article{Yang2024,
author = {Yang, Junyan and Yuan, Jiaqi and Huang, Yue and Rosenbaum, Anton I},
title = {Reference‐free thio‐succinimide isomerization characterization by electron‐activated dissociation},
journal = {Rapid Communications in Mass Spectrometry},
year = {2024},
doi = {10.1002/rcm.9910}
}
EUVIMED